gonorrhea%20-%20uncomplicated%20anogenital%20infection
GONORRHEA - UNCOMPLICATED ANOGENITAL INFECTION
Gonorrhea is a sexually or vertically transmitted infection secondary to Gram-negative diplococcus Neisseria gonorrhoeae.
It is one of the most common bacterial sexually transmitted infections that may cause pelvic inflammatory disease leading to infertility or ectopic pregnancy.
Most of the infected females are asymptomatic but may present with increased or altered vaginal discharge, dysuria, urethral discharge, abnormal vaginal bleeding, vulval itching or burning, dyspareunia, conjunctivitis and proctitis.

Gonorrhea - Uncomplicated Anogenital Infection References

  1. Van Vranken M. Prevention and treatment of sexually transmitted diseases: an update. Am Fam Physician. 2007 Dec;76(12):1827-1832. PMID: 18217521
  2. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009 Mar;10(4):555-577. http://www.ncbi.nlm.nih.gov. Accessed 23 Jun 2010. PMID: 19284360
  3. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR. 2007 Apr;56(14):332-336. http://www.cdc.gov. Accessed 23 Jun 2010. PMID: 17431378
  4. Hollier LM, Workowski K. Treatment of sexually transmitted infections in women. Infect Dis Clin North Am. 2008 Dec;22(4):665-691. doi: 10.1016/j.idc.2008.05.009. PMID: 18954758
  5. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR. 2006 Aug;55:1-94. http://www.cdc.gov. Accessed 21 Jun 2010. PMID: 16888612
  6. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonoccocal infections. MMWR. 2012 Aug;61(31):590-594. http://www.cdc.gov. Accessed 17 Sep 2012. PMID: 22874837
  7. Miller KE. Diagnosis and treatment of Neisseria gonorrhoeae infections. Am Fam Physician. 2006 May;73(10):1779-1784. http://www. afp.org. Accessed 23 Jun 2010. PMID: 16734055
  8. Moran JS, Newman LM, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis. 2007 Apr;44(Suppl 3):S84-S101. http://www.journals.uchicago.edu. Accessed 01 Jul 2010. PMID: 17342672
  9. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva: WHO. 2001
  10. U.S. Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann Fam Med. 2005 May;3(3)(Suppl 3):263-267. http://www.ncbi.nlm.nih.gov. Accessed 23 Jun 2010. PMID: 15928231
  11. Radcliffe K. European STD guidelines. Int J STD AIDS. 2001 Oct;12(Suppl 3):1-102. http://www.iusti.org. PMID: 11589789
  12. MedWorm http://www.medworm.com/rss/index.php/Dermatology/12/ http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology-News.xml
  13. MedWormhttp://www.medworm.com/rss/index.php/OBGYN/29/http://www.medworm.com/rss/medicalfeeds/specialities/OBGYN.xml
  14. National Guideline Clearinghouse. (1) Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (2) Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. http://www.guideline.gov. Accessed 21 Jun 2010.
  15. Expert Working Group on Canadian Guidelines for Sexually Transmitted Infections. Canadian guidelines on sexually transmitted infections: gonorrhea. http://www.phac-aspc.gc.ca. Accessed 01 Jul 2010.
  16. World Health Organization. Guidelines for the management of sexually transmitted infections. WHO. http://apps.who.int. 2004.
  17. Ministry of Health Singapore. Management of genital ulcers and discharges. MOH (Singapore). http://www.moh.gov.sg. 2009. Accessed 21 Jun 2010.
  18. Behrman AJ, Shoff WH. Gonorrhea. eMedicine. http://emedicine.medscape.com. 12 Nov 2009. Accessed 29 Mar 2010.
  19. Centers for Disease Control and Prevention. STD fact sheet: gonorrhea. CDC. http://www.cdc.gov. Accessed 21 Jun 2010.
  20. Bignell C, Fitzgerald M, Clinical Effectiveness Group British Association for Sexual Health and HIV. UK National guideline for the management of gonorrhea in adults. http://www.bashh.org. Jun 2011. Accessed 17 Sep 2010.
  21. British Association for Sexual Health and HIV Clinical Effectiveness Group. National guideline on the diagnosis and treatment of gonorrhoea in adults 2005. http://www.bashh.org. Accessed 29 Mar 2010.
  22. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae-2014. MMWR Recomm Rep. 2014 Mar;63(RR-02):1-19. http://www.cdc.gov. Accessed 29 Apr 2014. PMID: 24622331
  23. Centers for Disease Control and Prevention. STD surveillance case definitions. CDC. http://www.cdc.gov. 10 Dec 2013. Accessed 29 Apr 2014.
  24. Centers for Disease Control and Prevention. Two new promising treatment regimens for gonorrhea additional options urgently needed. CDC. http://www.cdc.gov. 27 Dec 2013. Accessed 29 Apr 2014.
  25. Ministry of Health Malaysia. National antibiotic guideline 2014, 2nd edition. Pharmaceutical Services Divisions, Ministry of Health Malaysia. http://www.pharmacy.gov.my. Dec 2014. Accessed 16 Jul 2015.
  26. World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae. WHO. http://www.who.int. 2016. Accessed 08 Sep 2016.
  27. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137. https://www.cdc.gov/std. PMID: 26042815
  28. Janda WM. Emerging extended-spectrum cephalosporin resistance in Neisseria gonorrhoeae. Clinical Microbiology Newsletter. 2016 Jan 15;38(2):9-18. http://dx.doi.org/10.1016/j.clinmicnews.2015.12.006.
  29. Swygard H, Sena AC, Cohen MS. Treatment of uncomplicated gonococcal infections. UpToDate. https://www.uptodate.com. 15 Feb 2017.
  30. LeFevre ML; U.S. Preventive Services Task Force. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Dec 16;161(12):902-910. doi: 10.7326/M14-1981. PMID: 25243785
  31. Alirol E, Wi TE, Bala M, et al. Multi-drug-resistant gonorrhea: a research & development roadmap to discover new medicines. World Health Organization (WHO). http://www.who.int. 2017.
  32. International Union Against Sexually Transmitted Infections (IUSTI). STI treatment pocket European guidelines 2018. IUSTI. https://www.iusti.org. 2018.
  33. Fifer H, Saunders J, Soni S, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019). BASHH. https://www.bashh.org. 2019.
  34. Swygard H, Sena AC, Cohen MS. Treatment of uncomplicated Neisseria gonorrhoeae infections. UpToDate. https://www.uptodate.com. 20 Nov 2018.
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 3 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
3 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.